Search research articles
Contact Us
Filters
Showing results (121-130 of 142) with videos related to
Page
of 15
Sort By:
Journal of Human Hypertension
|
April 1, 1997
Calcium channel blockers and cardiac mortality in the treatment of hypertension: a report from the Department of Health Hypertension Care Computing Project (DHCCP)
C J Bulpitt, A J Palmer, D G Beevers, et al.
Clinical Science (London, England : 1979)
|
June 1, 1989
Correlation of blood pressure in normotensive and hypertensive individuals with platelet but not lymphocyte intracellular free calcium concentrations
K Pritchard, A E Raine, C C Ashley, et al.
Clinical Science (London, England : 1979)
|
November 1, 1990
Evidence for abnormal Na+/H+ antiport activity detected by phosphorus nuclear magnetic resonance spectroscopy in exercising skeletal muscle of patients with essential hypertension
C R Dudley, D J Taylor, L L Ng, et al.
Advances in Experimental Medicine and Biology
|
January 1, 1977
Evidence for a relationship between plasma immunoreactive calcitonin and bone disease in chronic renal failure
J A Kanis, G Heynen, M Earnshaw, et al.
Lancet (London, England)
|
December 23, 1978
Results from a new renal transplantation unit
P J Morris, D Oliver, M Bishop, et al.
Human Immunology
|
October 1, 1987
Functional and biochemical subtypes of the haplotype HLA-DR3 in patients with celiac disease or idiopathic membranous nephropathy
S H Sacks, A Bushell, N A Rust, et al.
The New England Journal of Medicine
|
May 12, 1977
Changes in histologic and biochemical indexes of bone turnover after bilateral nephrectomy in patients on hemodialysis. Evidence for a possible role of endogenous calcitonin
J A Kanis, M Earnshaw, G Heynen, et al.
Clinical Science and Molecular Medicine
|
February 1, 1974
Proceedings: Some long-term effects of 1,25 dihydroxycholecalciferol (1,25(OH)2D3) in man
R G Henderson, J G Ledingham, D O Oliver, et al.
Lancet (London, England)
|
March 9, 1974
Effects of 1,25-dihydroxycholecalciferol on calcium absorption, muscle weakness, and bone disease in chronic renal failure
R G Henderson, R G Russell, J G Ledingham, et al.
Journal of Hypertension
|
September 1, 1995
Alcohol intake and cardiovascular mortality in hypertensive patients: report from the Department of Health Hypertension Care Computing Project
A J Palmer, A E Fletcher, C J Bulpitt, et al.
Page
of 15
Search research articles
Search
Showing results (121-130 of 142) with videos related to
Sort By:
Page
of 15
Journal of Human Hypertension
|
April 1, 1997
Calcium channel blockers and cardiac mortality in the treatment of hypertension: a report from the Department of Health Hypertension Care Computing Project (DHCCP)
C J Bulpitt, A J Palmer, D G Beevers, et al.
Clinical Science (London, England : 1979)
|
June 1, 1989
Correlation of blood pressure in normotensive and hypertensive individuals with platelet but not lymphocyte intracellular free calcium concentrations
K Pritchard, A E Raine, C C Ashley, et al.
Clinical Science (London, England : 1979)
|
November 1, 1990
Evidence for abnormal Na+/H+ antiport activity detected by phosphorus nuclear magnetic resonance spectroscopy in exercising skeletal muscle of patients with essential hypertension
C R Dudley, D J Taylor, L L Ng, et al.
Advances in Experimental Medicine and Biology
|
January 1, 1977
Evidence for a relationship between plasma immunoreactive calcitonin and bone disease in chronic renal failure
J A Kanis, G Heynen, M Earnshaw, et al.
Lancet (London, England)
|
December 23, 1978
Results from a new renal transplantation unit
P J Morris, D Oliver, M Bishop, et al.
Human Immunology
|
October 1, 1987
Functional and biochemical subtypes of the haplotype HLA-DR3 in patients with celiac disease or idiopathic membranous nephropathy
S H Sacks, A Bushell, N A Rust, et al.
The New England Journal of Medicine
|
May 12, 1977
Changes in histologic and biochemical indexes of bone turnover after bilateral nephrectomy in patients on hemodialysis. Evidence for a possible role of endogenous calcitonin
J A Kanis, M Earnshaw, G Heynen, et al.
Clinical Science and Molecular Medicine
|
February 1, 1974
Proceedings: Some long-term effects of 1,25 dihydroxycholecalciferol (1,25(OH)2D3) in man
R G Henderson, J G Ledingham, D O Oliver, et al.
Lancet (London, England)
|
March 9, 1974
Effects of 1,25-dihydroxycholecalciferol on calcium absorption, muscle weakness, and bone disease in chronic renal failure
R G Henderson, R G Russell, J G Ledingham, et al.
Journal of Hypertension
|
September 1, 1995
Alcohol intake and cardiovascular mortality in hypertensive patients: report from the Department of Health Hypertension Care Computing Project
A J Palmer, A E Fletcher, C J Bulpitt, et al.
Page
of 15